Share

August 2021; 11 (4) Research

Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis

A Nationwide Danish Cross-sectional Study

Johanna Balslev Andersen, Tine Iskov Kopp, Finn Sellebjerg, Melinda Magyari
First published February 3, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001035
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
141

Share

Article Information

vol. 11 no. 4 280-290
DOI: 
https://doi.org/10.1212/CPJ.0000000000001035
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received June 19, 2020
  • Accepted November 4, 2020
  • First Published February 3, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Johanna Balslev Andersen, MSc,
    2. Tine Iskov Kopp, MSc, PhD,
    3. Finn Sellebjerg, MD, PhD, DMCs and
    4. Melinda Magyari, MD, PhD
  1. Johanna Balslev Andersen, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Merck, funding for travel and congress participation

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Tine Iskov Kopp, MSc, PhD,
    3. Scientific Advisory Boards:

    1. (1) Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Finn Sellebjerg, MD, PhD, DMCs and
    4. Scientific Advisory Boards:

    1. Participation in advisory boards for Biogen, Merck, Novartis, Roche, Sanofi Genzyme.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel grants or speaker honoraria from Biogen, Merck, Novartis, Roche, Sanofi Genzyme, Teva.

    Editorial Boards:

    1. Section editor (immunology) for Multiple Sclerosis and Related Disorders since 2012

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Member of steering committee for clinical trials for Merck and Roche. Consulting work for Novartis.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support from Biogen, Merck, Novartis, Roche, Sanofi Genzyme.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Grant support from: Danish Multiple Sclerosis Society, the Johnsen Foundation, Foundation for Research in Neurology, the Friis Foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Melinda Magyari, MD, PhD
    5. Scientific Advisory Boards:

    1. (1)Biogen (2)Teva (3) Sanofi (3)Roche (4) Merck (5) Novartis (6) Alexion (7) Abbvie

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1)Biogen (2)Teva (3) Sanofi (4)Novartis (5) Almirall

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Roche (2) KORA: Det Nationale Institut for Kommuners og Regioners Analyse og Forskning (2) Department of Clinical Epidemiology Århus University

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Biogen (2)Teva (3) Sanofi (3)Roche (4) Merck (5) Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Danish Multiple Sclerosis Society Fonden for Neurologisk Forskning Direktør Ejnar Jonasson, kaldet Johnsen og Hustru’s Mindelegat Lundbeck Fonden

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.
  1. Correspondence
    Dr. Andersen johanna.balslev.andersen{at}regionh.dk
View Full Text

Article usage

Article usage: February 2021 to August 2023

AbstractFullPdfSource
Feb 20211097015Highwire
Mar 202134901Highwire
Apr 20218602Highwire
May 20219202Highwire
Jun 20217902Highwire
Jul 20216700Highwire
Aug 20213762919Highwire
Sep 202116318137Highwire
Oct 20212164624Highwire
Nov 2021175108Highwire
Dec 20216044Highwire
Jan 20226035Highwire
Feb 20228111Highwire
Mar 20229321Highwire
Apr 20226543Highwire
May 20228125Highwire
Jun 20224321Highwire
Jul 20226342Highwire
Aug 20227413Highwire
Sep 20227800Highwire
Oct 20225700Highwire
Nov 20229710Highwire
Dec 20224800Highwire
Jan 20235331Highwire
Feb 20237801Highwire
Mar 20232511Highwire
Apr 20234901Highwire
May 20234900Highwire
Jun 20234302Highwire
Jul 20234620Highwire
Aug 20232200Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles